Yingqiang Shi
- Molecular Biology top 10%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 5%
- Surgery top 10%
- Oncology top 10%
- Topics
- Sarcoma Diagnosis and Treatment (16 papers)Gastric Cancer Management and Outcomes (15 papers)Gastrointestinal Tumor Research and Treatment (11 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yingqiang Shi
48 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Molecular Biology 1.1k
- Cancer Research 933
- Pulmonary and Respiratory Medicine 614
- Surgery 342
- Oncology 335
Countries citing papers authored by Yingqiang Shi
This map shows the geographic impact of Yingqiang Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingqiang Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingqiang Shi more than expected).
Fields of papers citing papers by Yingqiang Shi
This network shows the impact of papers produced by Yingqiang Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingqiang Shi. The network helps show where Yingqiang Shi may publish in the future.
Co-authorship network of co-authors of Yingqiang Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Yingqiang Shi. A scholar is included among the top collaborators of Yingqiang Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingqiang Shi. Yingqiang Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 10 | |
| 5 | 19 | |
| 6 | Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancerbreakdown → | 580 |
| 7 | 14 | |
| 8 | 0 | |
| 9 | 14 | |
| 10 | 230 | |
| 11 | 45 | |
| 12 | 22 | |
| 13 | 26 | |
| 14 | 61 | |
| 15 | 55 | |
| 16 | 78 | |
| 17 | 31 | |
| 18 | Expression of PRL-3 gene in colorectal cancer and its clinical significance | 0 |
| 19 | Expression and prognostic significance of CD44v6 in primary gastric carcinoma | 1 |
| 20 | 13 |
About Yingqiang Shi
Yingqiang Shi is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 53 papers that have together received 1.9k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (16 papers), Gastric Cancer Management and Outcomes (15 papers) and Gastrointestinal Tumor Research and Treatment (11 papers). The work is most often cited by research in Cancer Research (933 citations), Gastroenterology (257 citations) and Pulmonary and Respiratory Medicine (614 citations). Yingqiang Shi has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yanong Wang, Biqiang Zheng, Ziwen Long, Huiyan Zhu, Xianghuo He, Ye Zhou, Ye Zhou, Chunmeng Wang, Yu Xu and Chunyang Bao. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and The Science of The Total Environment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.